Pharmacological properties of trimebutine and N- monodesmethyltrimebutine

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1391-1397

  Roman, Francois J ^a   Lanet, Sandrine ^a   Hamon, Jacques ^a   Brunelle, Gilles ^a   Maurin, Anne ^b   Champeroux, Pascal ^b   Richard, Serge ^b   Alessandri, Nicole ^c   Gola, Maurice ^c  

^a Institut de Recherche Jouveinal   (France)

^b Centre de Recherches Biologiques   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BATRACHOTOXIN; BENZOIC ACID DERIVATIVE; BUPIVACAINE; CALCIUM; FLUNARIZINE; GLUTAMIC ACID; LIDOCAINE; MEBEVERINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; N MONODESMETHYLTRIMEBUTINE; PHLOROGLUCINOL; PINAVERIUM; POTASSIUM; SODIUM; SODIUM CHANNEL; TRIMEBUTINE; UNCLASSIFIED DRUG; VERATRIDINE;

ANESTHESIA MECHANISM; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CORNEA REFLEX; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; LOCAL ANESTHESIA; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; SODIUM CURRENT; SPASMOLYSIS; SPINAL GANGLION;

ANIMALS; BATRACHOTOXINS; BINDING, COMPETITIVE; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; CORNEA; EMBRYO; FEMALE; GANGLIA, SPINAL; GLUTAMIC ACID; HUMANS; INTRACELLULAR MEMBRANES; KV1.1 POTASSIUM CHANNEL; KV1.2 POTASSIUM CHANNEL; LIDOCAINE; MALE; MEMBRANE POTENTIALS; NEURONS; OOCYTES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; STEREOISOMERISM; SYNAPTOSOMES; TRIMEBUTINE; XENOPUS LAEVIS;

EID: 0032990130     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Allescher HD, Ahmad S, Classen M and Daniel EE (1991) Interaction of trimebutine and JO-1196 (fedotozine) with opioid receptors in the canine ileum. J Pharmacol Exp Ther 257:836-842.
2. Battaglia G and Rustioni A (1988) Coexistence of glutamate and substance P in dorsal root ganglion cells of the rat and monkey. J Comp Neurol 27:302-312.
3. Bean BP, Cohen CJ and Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613-642.
4. Bourget P and Delouis JM (1993) Review of a technic for the estimation of area under the concentration curve in pharmacokinetic analysis. Therapie 48:1-5.
5. Bradette M, Delvaux M, Staumont G, Fioramonti G, Bueno L and Frexinos J (1994) Evaluation of colonic sensory thresholds in IBS patients using a barostat: Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci 39:449-457.
6. Bueno L, Honde C, Pascaud X and Junien JL (1987) Effects of orally versus parenterally administrated trimebutine on gastrointestinal and colonic motility in dogs. Gastroenterol Clin Biol 11:90B-93B.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-4002.
8. Coderre TJ and Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670.
9. Delis C, Walker EA, Castillo FD, Evans DF, Wingate DL, Allouche S and Van Egroo LD (1994) The effect of stress and opioid agonist on postprandial motor activity in the human small bowel (Abstract). Gastroenterology 106:A485.
10. Dickenson AH (1995) Spinal cord pharmacology of pain. Br J Anesth 75:193-200.
11. Dray A, Urban L and Dickenson A (1994) Pharmacology of chronic pain. Trends Pharmacol Sci 15:190-197.
12. Frexinos J, Fioramonti J and Bueno L (1985) Effect of trimebutine on colonic myoelectrical activity in IBS patients. Eur J Clin Pharmacol 28:181-185.
13. Ghidini O, Saponati G and Intrieri L (1986) Single drug treatment for irritable colon: Rociverine versus trimebutine maleate. Curr Ther Res 39:541-548.
14. Grandjouan S, Chaussade S, Couturier D, Thierman-Duffaud D and Henry JF (1989) A comparison of metoclopramide and trimebutine on small bowel motility in humans. Aliment Pharmacol Ther 3:387-393.
15. Julia V, Coelho AM, Rouzade MI, Allouche S and Bueno L (1996) Influence de la trimébutine (Débridat) sur l'hypomotricité colique et les crampes abdominales liées & la distension rectale chez le rat. Med Chir Dig 25:239-242.
16. Lees G and Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res 612:190-199.
17. Lüttecke K (1980) A three part controlled study of trimebutine in the treatment of irritable colon syndrome. Curr Med Res Opin 6:437-443.
18. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ and Frenk H (1993) Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 605:164-168.
19. Matesson DR and Armstrong CM (1984) Na and Ca channels in a transformed line of anterior pituitary cells. J Gen Physiol 83:371-394.
20. McPherson GA (1985) Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-228.
21. Meert TF and Melis W (1992) Interactions between epidurally and intrathecally administered sufentanil and bupivacaine in hydroxypropyl-β-cyclodextrin in the rat. Acta Anesthesiol Belg 43:79-89.
22. Meunier P (1980) Effet de la trimébutine sur la motricité colique dans les colopathies (Abstract). Gastroenterol Clin Biol 4:261A.
23. Moshal MG and Herron M (1979) A clinical trial of trimebutine in spastic colon. J Int Med Res 7:231-234.
24. Nagasaki M, Komori S and Ohashi H (1993a) Effect of trimebutine on voltage-activated calcium current in rabbit ileal smooth muscle cells. Br J Pharmacol 110:399-403.
25. + current in rabbit ileal smooth muscle cells. Eur J Pharmacol 238:197-203.
26. Pascaud X, Roman F, Petoux F, Vauche D and Junien JL (1987) Action de la trimebutine sur la motricité gastro-intestinale. Gastroenterol Clin Biol 11:77B-81B.
27. Reboa G, Bertoglio C, Terrizzi A and Parodi E (1976) L'azione della trimebutina sull'attivita elettrica e manometrica del colon normale e patologico. Riv Gastroenterol 28:1-16.
28. Roman F, Pascaud X, Taylor JE and Junien JL (1987) Interactions of trimebutine with guinea pig opioid receptors. J Pharm Pharmacol 39:404-407.
29. Sanguinetti MC and Kass RS (1984) Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55:336-348.
30. Schang JC, Devroede G and Pilote M (1993) Effect of trimebutine on colonic function in patients with chronic idiopathic constipation: Evidence for the need of a physiologic rather than clinical selection. Dis Colon Rectum 36:330-336.
31. Strichartz G and Ritchie J (1987) The action of local anesthetics on ion channels of excitable tissues, in Local Anesthetics Handbook of Experimental Pharmacology (Strichartz G ed) pp 21-52, Springer-Verlag, Heidelberg.
32. Toussaint J, Cremer M and Pintens H (1981) Etude en simple aveugle de trimébutine et de la mébévérine dans le côlon irritable et la dyspepsie. Acta Ther 7:261-268.
33. Triggle DJ (1997) Stereoselectivity of drug action (Review). Drug Discovery Today 2:138-147.
34. Turner TJ and Dunlap K (1995) Prolonged time course of glutamate release from nerve terminals: Relationship between stimulus duration and the secretory event. J Neurochem 64:2022-2033.
35. Urban L, Thompson SWN and Dray A (1994) Modulation of spinal excitability: Co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci 17:432-438.
36. Valmier J, Simmoneau M and Boisseau S (1989) Expression of voltage-dependent sodium and transient potassium currents in an identified subpopulation of dorsal root ganglion cells acutely isolated from 12-day-old mouse embryos. Pfluegers Arch 414:360-368.
37. Wang H, Kunkel DD, Schwartzkroin PA and Tempel BL (1994) Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J Neurosci 14:4588-4599.
38. Wermelskirchen D, Wilffert B and Peters TJ (1992) Veratridine-induced intoxication: An in vitro model for the characterization of anti-ischemic compounds. Basic Clin Physiol Pharmacol 3:293-321.